IARTIntegra LifeSciences Holdings Corporation

$747M

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$395M+3.1% YoY

Gross Profit

$246M62.2% margin

Operating Income

$36M9.1% margin

Net Income

$15M3.9% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+4.2%

Cash Flow

Operating Cash Flow

$89M

Free Cash Flow

$67M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.9B

Stockholders' Equity

$1.4B

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$395M	$383M	+3.1%
Gross Profit	$246M	$237M	+3.7%
Operating Income	$36M	$34M	+5.8%
Net Income	$15M	$25M	-39.1%

Revenue Segments

Codman Specialty Surgical

$259M66%

Orthopedics and Tissue Technologies

$136M34%

Geographic Segments

UNITED STATES

$281M71%

Europe

$49M12%

Asia Pacific

$43M11%

Rest Of World

$23M6%

IART Q4 2019 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena